Bionano Genomics, Inc. — Director's Dealing 2021

Jan 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2021-01-22

Reporting Person: Stewart Christopher P. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-22	Common Stock	A	8000	$6.00	Acquired	8000	Direct

Footnotes

F1: Acquired from the Issuer pursuant to an Underwriting Agreement dated January 20, 2021 with a closing date of January 22, 2021. The Underwriting Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors.